<p>From the reviews:</p><p>“This book discusses the epidemiology, pathophysiology, and medical management of kidney disease arising from heart failure. … designed to support the understanding and management of CKD in patients with heart failure, reviewing current practice in managing cardiorenal syndromes and concluding with advances in nephropathy management in patients … . Written by respected cardiologists and nephrologists, the book is intended for clinicians in both areas. … a well-written book that will prove useful in an academic healthcare setting or as continuing education for practice updates.” (Melissa K. Soper, Doody’s Review Service, January, 2013)</p>

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.

 

The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included.  Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.

 

This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.

Les mer
The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.

The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.

Les mer

Epidemiology of chronic kidney disease in heart failure.- Anemia and cardiovascular risk in the kidney disease patient.- Renal hemodynamic changes in heart failure.- Changes in kidney function following heart failure treatment: Focus on RAS Blockade.- Extracellular fluid volume in the hypoalbuminemic diabetic patient.- B-Type natriuretic peptide: Beyond a diagnostic criteria.- Hyperkalemia risk and treatment of heart failure.- Management of heart failure with renal artery ischemia.- Treatment of hypertension in heart failure with renal artery ischemia: Role of the kidney.- Renal consequences of prostaglandin inhibition in heart failure.- Edema mechanisms in the heart failure patient and treatment options.- Ultrafiltration for volume control in decompensated heart failure / Combination therapies.- Cost benefits of minimizing pill counts and dosing regimens.- New markers of vascular risk.- Dietary paradoxes to optimize cardiovascular risk management in CKD.

Les mer

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.

 

The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included.  Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.

 

This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.

Les mer
Few published books on this topic Complete coverage of topic Contributions by cardiologists and nephrologists
GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com
Les mer

Produktdetaljer

ISBN
9781489998118
Publisert
2014-08-08
Utgiver
Springer-Verlag New York Inc.; Springer-Verlag New York Inc.
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Heftet

Redaktør

Om bidragsyterne

Dr. Bakris is currently Professor of Medicine and Director of the Hypertension Center at the University of Chicago Pritzker School of Medicine. Dr. Bakris has published over 600 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. Additionally, he is the Associate Editor of the International Textbook of Cardiology. He chaired the first National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000). He has also served on many national guideline committees including: JNC VI and 7 writing committees, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline Committee. Dr. Bakris is also the past-president of the American College of Clinical Pharmacology and the current President of the American Society of Hypertension (ASH) (2010-2012). He is the current Editor of American Journal of Nephrology and Hypertension, Section Editor of Up-to-Date and Associate Editor of Diabetes Care and Nephrology, Dialysis & Transplant.